睿远成长价值混合：三季度重点配置了光模块、PCB等板块 依旧看好人工智能

Core Viewpoint - The report highlights the investment strategy of the Ruiyuan Growth Value Mixed Securities Investment Fund, focusing on sectors such as internet technology, optical modules, PCB, chips, and innovative pharmaceuticals, while maintaining a positive outlook on artificial intelligence despite market concerns [1] Group 1: Investment Focus - The fund has prioritized investments in internet technology, optical modules, PCB, chips, and innovative pharmaceuticals during the third quarter [1] - There is a focus on domestic companies within the PCB, optical module, and chip sectors, indicating a trend towards localization [1] Group 2: Market Sentiment - The significant short-term gains in the artificial intelligence sector have led to market divergence and concerns regarding the effectiveness of large capital expenditures by tech giants [1] - Despite these concerns, the industry is viewed as being in the early stages of development, suggesting potential for future growth [1] Group 3: Innovative Pharmaceuticals - The valuation of innovative pharmaceuticals is currently high, but the trend of Chinese innovative drug companies moving towards globalization remains unchanged [1] - The fund prefers companies with first-in-class and best-in-class potential, focusing on those with differentiated innovative drugs [1]